Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03037112 · ClinicalTrials.gov registry record · NA
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 1,600
- Enrollment target
NCT03037112: Completed NA study, sponsored by Children's Mercy Hospital Kansas City.
NCT03037112 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 1,600 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03037112, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,600 participants
- Enrollment target
Study Summary
Antibiotic overuse and misuse contributes to the development of antibiotic resistant infections and adverse drug reactions. The majority of all antibiotic prescribing occurs in outpatient settings; most of which are for respiratory illnesses. It is estimated that 50% of these prescriptions are unnecessary. The most important factor that leads to overprescribing is inadequate parent-provider communication. This study will recruit providers and eligible parents of children 1-5 years of age. Parents in both arms will receive identical brief antibiotic education via tablet computers. Providers will be randomized to the parent-provider education or communication skills intervention arm and trained accordingly. Parent data will be collected via a tablet computer RedCap survey administered in the exam room prior and immediately following the child's visit. Additional data will be garnered from the medical record (antibiotic prescribing) and a 2-week follow-up telephone call with parents (re-visits and adverse drug reactions).
Primary Outcome
Patient medical records will be reviewed 2 weeks after the visit to determine the clinical diagnosis and whether or not antibiotics were given. Determination will be made regarding the appropriateness of the diagnosis and prescribing using current clinical practice guidelines.
Interventions
- BEHAVIORAL Education
- BEHAVIORAL Communication Skills
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,600 participants |
| Start Date | 2017-03-03 |
| Est. Completion | 2019-04-30 |
| Phase | NA |
What the finished NCT03037112 record still lists
NCT03037112 is an interventional study that assigns participants to a tested intervention. Its 1,600 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (14% higher).
The record links to 0 conditions, and to 2 interventions - of which Education is the first listed.
NCT03037112 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03037112 about?
NCT03037112 is a clinical study titled "Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse". Antibiotic overuse and misuse contributes to the development of antibiotic resistant infections and adverse drug reactions. The majority of all antibiotic prescribing occurs in outpatient settings; most of which are for respiratory illnesses. It is estimated that 50% of these prescriptions are unnec...
What is the current status of trial NCT03037112?
This trial is currently completed. It is a NA study. The enrollment target is 1,600 participants. The study started on 2017-03-03. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT03037112?
The interventions under investigation include: Education (BEHAVIORAL), Communication Skills (BEHAVIORAL).
Who is sponsoring clinical trial NCT03037112?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03037112's enrollment target sits among peer trials
1,600 63rd of 2000 higher than 1,937 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00646022 · 1,600 participants
Natural History of Familial Carcinoid Tumor
- NCT03109197 · 1,600 participants
Sudden Unexplained Death in Childhood (SUDC) Registry
- NCT03511118 · 1,600 participants
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- NCT04314401 · 1,600 participants
National Cancer Institute "Cancer Moonshot Biobank"
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI